Tactile Systems Technology (TCMD) VP sells stock sale in 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tactile Systems Technology’s Senior Vice President of Marketing & Clinical Affairs, Kristie Burns, reported a planned sale of company stock. On January 2, 2026, she sold 5,139 shares of common stock at a price of $28.85 per share under transaction code “S,” which indicates a sale. After this trade, she beneficially owned 72,401 shares of Tactile Systems Technology common stock in direct ownership.
The sale was made pursuant to a Rule 10b5-1(c) trading plan, which the disclosure notes was adopted on September 11, 2025. Such plans allow insiders to prearrange trades of company stock according to preset instructions, helping separate personal trading decisions from access to inside information.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,139 shares ($148,260)
Net Sell
1 txn
Insider
Burns Kristie
Role
Sr. VP Mktg & Clinical Affairs
Sold
5,139 shs ($148K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,139 | $28.85 | $148K |
Holdings After Transaction:
Common Stock — 72,401 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did TCMD executive Kristie Burns report?
Kristie Burns, Senior Vice President of Marketing & Clinical Affairs at Tactile Systems Technology, reported selling 5,139 shares of common stock on January 2, 2026.
Was the TCMD insider sale made under a Rule 10b5-1 trading plan?
Yes. The filing states that the transaction was made under a Rule 10b5-1(c) trading plan, with an adoption date of September 11, 2025.
What is the role of the reporting person at Tactile Systems Technology (TCMD)?
The reporting person, Kristie Burns, serves as Senior Vice President, Marketing & Clinical Affairs at Tactile Systems Technology.
Is this TCMD Form 4 filed by more than one reporting person?
No. The document indicates that the Form 4 was filed by one reporting person, Kristie Burns.